On the basis of the recommendations reported in step 5 of GINA (Global Initiative for Asthma) guidelines [101], currently available biological therapies for severe asthma include anti-IgE, anti-IL-5, anti-IL-5R and anti-IL-4R add-on treatments (Figure 1). The gene discussed is IL5; the disease is asthma.